Tag: SKCM

SLC25A13 Could Be Prognostic, Therapeutic Biomarker in Skin Cutaneous Melanoma

The analysis suggests the marker could be used to screen patients for potential immunotherapy. Solute carrier family 25 member 13 (SLC25A13) may be a powerful prognostic biomarker in patients with skin cutaneous melanoma (SKCM), according to new research. The study, published in Disease Markers, showed that patients with SKCM who…

Continue Reading SLC25A13 Could Be Prognostic, Therapeutic Biomarker in Skin Cutaneous Melanoma

Role of CD68 in tumor immunity and prognosis prediction in pan-cancer

Expression of CD68 in pan-cancer First, to fully clarify the expression of CD68 in pan-cancer, we matched the GTEx normal samples with TCGA tumor samples (Fig. 1A). We found that the levels of CD68 were significantly elevated (P < 0.01) in colon adenocarcinoma (COAD), glioblastoma multiforme (GBM), kidney renal clear cell carcinoma (KIRC),…

Continue Reading Role of CD68 in tumor immunity and prognosis prediction in pan-cancer

Skin cutaneous melanoma properties of immune-related lncRNAs identifying potential prognostic biomarkers

. 2022 Mar 31;14(undefined). doi: 10.18632/aging.203982. Online ahead of print. Affiliations Expand Affiliations 1 Department of Breast Surgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, P.R. China. 2 Department of Plastic Surgery, The First Hospital of China Medical University, Shenyang 110001, Liaoning Province, P.R. China. 3…

Continue Reading Skin cutaneous melanoma properties of immune-related lncRNAs identifying potential prognostic biomarkers

Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming

Background: Thymidine kinase 1 (TK1) is a cell cycle-dependent kinase that catalyzes the addition of a gamma-phosphate group to thymidine. The protumorigenic role of TK1 has been reported in various malignancies. However, the role of TK1 in skin cutaneous melanoma (SKCM) remains unclear. This study aimed to explore the molecular…

Continue Reading Thymidine Kinase 1 Drives Skin Cutaneous Melanoma Malignant Progression and Metabolic Reprogramming

The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma

Skin cutaneous melanoma (SKCM) is a type of highly invasive cancer originated from melanocytes. It is reported that aberrant alternative splicing (AS) plays an important role in the neoplasia and metastasis of many types of cancer. Therefore, we investigated whether ASEs of pre-RNA have such an influence on the prognosis…

Continue Reading The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma

Index of /runs/gdc/report_2018_02_16

Name Last modified Size Description Parent Directory   –   TCGA-ACC.2018_02_16.diced_metadata.tsv 2018-02-16 01:06 250K   TCGA-ACC.2018_02_16.high_res.heatmap.png 2018-02-16 01:08 73K   TCGA-ACC.2018_02_16.low_res.heatmap.png 2018-02-16 01:08 37K   TCGA-ACC.2018_02_16.sample_counts.tsv 2018-02-16 01:06 142   TCGA-BLCA.2018_02_16.diced_metadata.tsv 2018-02-16 01:06 1.2M   TCGA-BLCA.2018_02_16.high_res.heatmap.png 2018-02-16 01:08 90K   TCGA-BLCA.2018_02_16.low_res.heatmap.png 2018-02-16 01:08 53K   TCGA-BLCA.2018_02_16.sample_counts.tsv 2018-02-16 01:06 201  …

Continue Reading Index of /runs/gdc/report_2018_02_16

How to access WGS files on TCGA for melanoma/SKCM

How to access WGS files on TCGA for melanoma/SKCM 0 I was trying to find WGS files for TCGA-SKCM so I can run WGS files through our pipeline and search for circular DNA elements in melanoma samples. However, looking on the TCGA website for this type of cancer, it’s unclear…

Continue Reading How to access WGS files on TCGA for melanoma/SKCM